EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Senescent Cells: A Therapeutic Target in Cardiovascular Diseases

Masayoshi Suda iD, Karl H Paul iD, Tohru Minamino, Jordan D Miller, Amir Lerman, Georgina M Ellison-Hughes iD, Tamar Tchkonia, James L Kirkland

Cells · 02.05.2023 · 12 (9) · 1296

DOI: 10.3390/cells12091296 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 02.05.2023. Verfasst von Masayoshi Suda und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Biomedical Engineering, Mayo Clinic, 200 First St., S.W., Rochester, MN 55905, USA. Hauptthemen laut MEDLINE: Senotherapeutics, Cardiovascular Diseases. Die Arbeit wurde bisher 118-mal zitiert (Crossref) und nennt 306 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIDDK NIH HHS, US National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Senescent cell accumulation has been observed in age-associated diseases including cardiovascular diseases. Senescent cells lack proliferative capacity and secrete senescence-associated secretory phenotype (SASP) factors that may cause or worsen many cardiovascular diseases. Therapies targeting senescent cells, especially senolytic drugs that selectively induce senescent cell removal, have been shown to delay, prevent, alleviate, or treat multiple age-associated diseases in preclinical models. Some senolytic clinical trials have already been completed or are underway for a number of diseases and geriatric syndromes. Understanding how cellular senescence affects the various cell types in the cardiovascular system, such as endothelial cells, vascular smooth muscle cells, fibroblasts, immune cells, progenitor cells, and cardiomyocytes, is important to facilitate translation of senotherapeutics into clinical interventions. This review highlights: (1) the characteristics of senescent cells and their involvement in cardiovascular diseases, focusing on the aforementioned cardiovascular cell types, (2) evidence about senolytic drugs and other senotherapeutics, and (3) the future path and clinical potential of senotherapeutics for cardiovascular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SenotherapeuticsCardiovascular DiseasesHumansEndothelial CellsCellular SenescenceHeart

Stichwörter der Autor:innen

SASPatherosclerosiscardiovascular diseasescellular senescencesenolytics

Substanzen

Senotherapeutics

Autor:innen und Institutionen

  • Department of Physiology and Biomedical Engineering, Mayo Clinic, 200 First St., S.W., Rochester, MN 55905, USA.
  • Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 3-1-3 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
  • Department of Physiology and Pharmacology, Karolinska Institutet, Solnavägen 9, 171 65 Solna, Sweden.
  • Japan Agency for Medical Research and Development-Core Research for Evolutionary Medical Science and Technology (AMED-CREST), Japan Agency for Medical Research and Development, Tokyo 100-0004, Japan.
  • Division of Cardiovascular Surgery, Mayo Clinic College of Medicine, 200 First St., S.W., Rochester, MN 55905, USA.
  • Department of Cardiovascular Medicine, Mayo Clinic, 200 First St., S.W., Rochester, MN 55905, USA.

ORCID-Profile: Masayoshi Suda, Karl H Paul, Georgina M Ellison-Hughes

Förderung

  • NIA NIH HHS
  • NIDDK NIH HHS
  • US National Institutes of Health
  • a Grant-in-Aid for Scientific Research (A)
  • Grant-in-Aid for Challenging Research (Pioneering)
  • MEXT, AMED-CREST
  • the Moonshot Research and Development Program
  • Heart Research

Zitieren

APA

Suda, M., Paul, K. H., Minamino, T., Miller, J. D., Lerman, A., Ellison-Hughes, G. M., Tchkonia, T., & Kirkland, J. L. (2023). Senescent Cells: A Therapeutic Target in Cardiovascular Diseases. Cells, 12(9), 1296. https://doi.org/10.3390/cells12091296

Vancouver

Suda M, Paul KH, Minamino T, Miller JD, Lerman A, Ellison-Hughes GM, et al. Senescent Cells: A Therapeutic Target in Cardiovascular Diseases. Cells. 2023;12(9):1296. doi:10.3390/cells12091296

BibTeX
@article{Suda2023,
  author = {Suda, Masayoshi and Paul, Karl H and Minamino, Tohru and Miller, Jordan D and Lerman, Amir and Ellison-Hughes, Georgina M and Tchkonia, Tamar and Kirkland, James L},
  title = {Senescent Cells: A Therapeutic Target in Cardiovascular Diseases},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {9},
  pages = {1296},
  doi = {10.3390/cells12091296}
}
Kostenlos starten →